Information Provided By:
Fly News Breaks for September 27, 2019
Sep 27, 2019 | 09:08 EDT
Dougherty analyst Kyle Bauser said that National Government Services and CGS Administrators issued positive draft policies for the Inspire therapy that were consistent with the previous draft local coverage determinations, or LCDs. He notes that, including those two, six Medicare Administrative Contractors, or MACs, have issued positive LCD drafts covering 44 states and said he expects the one remaining MAC to follow suit. Bauser reiterated a Buy rating and $78 price target on Inspire Medical shares.
News For INSP From the Last 2 Days
There are no results for your query INSP